Last reviewed · How we verify
Gensigen — Competitive Intelligence Brief
unknown
gentisic acid
Arachidonate 5-lipoxygenase, Carbonic anhydrase 1, Carbonic anhydrase 12
Other
Live · refreshed every 30 min
Target snapshot
Gensigen (gentisic acid). Gensigen works by blocking the enzyme carbonic anhydrase 2, which helps regulate the balance of fluids and electrolytes in the body.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Gensigen TARGET | gentisic acid | unknown | gentisic acid | Arachidonate 5-lipoxygenase, Carbonic anhydrase 1, Carbonic anhydrase 12 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (gentisic acid class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Gensigen CI watch — RSS
- Gensigen CI watch — Atom
- Gensigen CI watch — JSON
- Gensigen alone — RSS
- Whole gentisic acid class — RSS
Cite this brief
Drug Landscape (2026). Gensigen — Competitive Intelligence Brief. https://druglandscape.com/ci/gentisic-acid. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing